Presentation Information

[S3-5]The Contribution of Aging to the Development of Immune-Related Adverse Events Associated with Cancer Immunotherapy

○Hirotake Tsukamoto1 (1. Center for Cancer Immunotherapy and Immunobiology, Kyoto University (Japan))

Password required to view


Comment

To browse or post comments, you must log in.Log in